Category: Patent & Other IP Offices
-
EPO Enlarged Board limits mandatory description amendments in G 1/25
The EPO Enlarged Board of Appeal has ruled that amended claims do not automatically require corresponding changes to the description, while reinforcing the description’s role in claim interpretation.
-
Podcast: interview with WIPO’s Heike Wollgast on SEP mediation pledge, role of alternative dispute resolution in patent litigation
In our latest podcast episode, ip fray interviewed Heike Wollgast, who heads up the IP Disputes Section of the World Intellectual Property Organization’s Arbitration and Mediation Center.
-
Accord slapped with injunction in Munich after invalidity losses in EPO, German Federal Patent CourtÂ
The Munich I Regional Court has found that Accord infringed TOWA’s dabigatran etexilate patent, issuing an injunction against the company. Dabigatran etexilate is an oral anticoagulant medicine that stops blood clots from forming, preventing strokes, deep vein thrombosis, and pulmonary embolism, among other things.
-
Patent owner asks USPTO Director to terminate Google-triggered reexam, points to pattern of 21 do-overs after failed IPRs
A patent owner has asked the USPTO Director to end a Google-triggered reexam, citing a pattern in which Google filed at least 21 ex parte reexams after losing IPR challenges.
-
Maxell acquires TCL patents following settlement of district court litigation and ITC complaint; initiates new Hisense suit
The Japanese company is also locked in an ongoing dispute with Samsung.
-
WIPO publishes Ericsson’s 6G foundation patent application
The World Intellectual Property Office has published Ericsson’s 6G foundation patent application, marking an important first step in the company’s ambitions to stay ahead in the 6G SEP race.
-
Former USPTO deputy director Coke Stewart on C4IP President appointment
“There is a concern that the pendulum is swinging back and forth from one director to another, or one administration to another. While there isn’t an agreement on what the reforms should be, there is consensus that the changes need to be permanent, and I can better do that from the outside,” Ms. Stewart told…
-
Canadian Solar, Maxeon settle U.S. patent dispute
The Eastern District of Texas has dismissed Maxeon’s suit against Canadian Solar with prejudice, while the Federal Circuit has vacated the relevant portion of a PTAB decision relating to Maxeon’s remaining claim, resolving the case in Canadian Solar’s favor.
-
Federal Circuit affirms invalidation of Nielsen’s audience-measurement patent, backs PTAB’s “reasonably pertinent” prior art finding
The Federal Circuit affirmed a PTAB ruling invalidating Nielsen’s audience-measurement patent, holding that a facial-expression research paper qualified as “reasonably pertinent” prior art despite coming from a different research field.
-
EWHC hinders Accord’s plans to launch Entresto competing product in Novartis patent dispute
Mr. Justice Meade of the High Court of Justice for England & Wales has held that all of Accord’s “attacks” on a Novartis Entresto patent have failed, and its own intended competing product would infringe the defendant’s supplementary protection certificate.